Beyond Tax Benefits: Portfolio Opportunities In A Pfizer-Allergan Deal

Pfizer Inc. and Allergan plc continue to be in closed-door discussions regarding a potential merger that could significantly cut Pfizer's tax rate due to Allergan's Irish corporate base, but Allergan also has several commercial products and research-stage assets that could fill gaps in Pfizer's portfolio.